Literature DB >> 2492714

Embolization of branches arising from the cavernous portion of the internal carotid artery.

V V Halbach1, R T Higashida, G B Hieshima, C W Hardin.   

Abstract

Seven patients with vascular disease (four with cavernous and two with transverse sinus dural fistulas and one with a facial arteriovenous malformation, all supplied primarily from cavernous branches of the internal carotid artery) underwent subselective catheterization and embolization. Ten branches were catheterized (seven meningohypophyseal trunks and three inferolateral trunks) and eight branches were embolized. The embolic agents were as follows: polyvinyl alcohol particles in five, hypertonic glucose in two, and liquid adhesive in one. All four cavernous sinus dural fistulas were occluded after embolization. In the two transverse sinus fistulas, the goal of embolization was to obliterate the tentorial supply prior to surgery. This goal was achieved in both cases. In the remaining patient, who had a large facial arteriovenous malformation and recurrent epistaxis, the embolization obliterated the cavernous supply to the nasal cavity and the patient remains hemorrhage-free. Despite one complication, which occurred in the first case when a thrombus formed and dislodged, resulting in an embolic stroke, this study shows that subselective catheterization and embolization can obliterate lesions of the branches arising from the cavernous internal carotid artery.

Entities:  

Mesh:

Year:  1989        PMID: 2492714      PMCID: PMC8335076     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  12 in total

1.  Endovascular access to the meningohypophyseal trunk.

Authors:  N M Borden; K M Liebman
Journal:  AJNR Am J Neuroradiol       Date:  2001-04       Impact factor: 3.825

2.  Targeted compartmental embolization of cavernous sinus dural arteriovenous fistulae using transfemoral medial and lateral facial vein approaches.

Authors:  R Agid; R A Willinsky; C Haw; M P S Souza; I J Vanek; K G terBrugge
Journal:  Neuroradiology       Date:  2003-12-04       Impact factor: 2.804

3.  Laser-assisted bypass of the internal carotid artery prior to treatment of an extensive angiofibroma.

Authors:  K Graamans; C A Tulleken
Journal:  Skull Base Surg       Date:  1998

4.  Tentorial artery embolization in tentorial dural arteriovenous fistulas.

Authors:  Willem Jan van Rooij; Menno Sluzewski; Guus N Beute
Journal:  Neuroradiology       Date:  2006-08-04       Impact factor: 2.804

5.  The artery of Bernasconi and Cassinari: a morphometric study for superselective catheterization.

Authors:  A D Banerjee; H Ezer; A Nanda
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-22       Impact factor: 3.825

6.  Strategies for embolization of the internal carotid artery for cavernous sinus tumors.

Authors:  C A Jungreis
Journal:  Skull Base Surg       Date:  1991

7.  Preoperative embolization of brain tumor with pial artery or dural branch of internal carotid artery as feeding artery.

Authors:  M Hirohata; T Abe; N Fujimura; Y Takeuchi; M Shigemori
Journal:  Interv Neuroradiol       Date:  2006-06-15       Impact factor: 1.610

8.  Transvenous embolization for dural arteriovenous shunt of the cavernous sinus. Comparison of multi-staged transvenous embolization and transvenous embolization with sinus packing.

Authors:  S Kato; H Ishihara; H Nakayama; M Fujii; H Fujisawa; K Kajiwara; S Nomura; H Sadanaga; M Suzuki
Journal:  Interv Neuroradiol       Date:  2008-02-01       Impact factor: 1.610

9.  Endovascular treatment of high-risk tentorial dural arteriovenous fistulas: clinical outcomes.

Authors:  Chuhan Jiang; Xianli Lv; Youxiang Li; Jingbo Zhang; Zhongxue Wu
Journal:  Neuroradiology       Date:  2008-11-07       Impact factor: 2.804

10.  Transvenous embolization of dural caroticocavernous fistulae: technical considerations.

Authors:  K Yamashita; W Taki; S Nishi; A Sadato; I Nakahara; H Kikuchi; Y Yonekawa
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.